Acceptance of an ABO-Incompatible Mismatched (AB+ to O+) Liver Allograft With the Use of Daclizumab and Mycophenolate Mofetil
Author:
Publisher
Wiley
Subject
Transplantation,Hepatology,Surgery
Reference8 articles.
1. THE USE OF ABO-INCOMPATIBLE GRAFTS IN LIVER TRANSPLANTATION
2. ABO BLOOD GROUP INCOMPATIBILITY IN LIVER TRANSPLANTATION: A SINGLE-CENTRE EXPERIENCE
3. SUCCESSFUL USE OF AN ENHANCED IMMUNOSUPPRESSIVE PROTOCOL WITH PLASMAPHERESIS FOR ABO-INCOMPATIBLE MISMATCHED GRAFTS IN LIVER TRANSPLANT RECIPIENTS
4. RISK FACTORS FOR LIVER TRANSPLANTATION ACROSS THE ABO BARRIER
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ABO Incompatible Liver Transplantation in Children: A 20 Year Experience from Centres in the TransplantChild European Reference Network;Children;2021-08-31
2. ABO, Tissue Typing, and Crossmatch Incompatibility;Transplantation of the Liver;2015
3. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue;Journal of Clinical Apheresis;2013-06
4. Emergency ABO-incompatible liver transplant secondary to fulminant hepatic failure: Outcome, role of TPE and review of the literature;Journal of Clinical Apheresis;2012
5. Successful Long-term Outcome of ABO-incompatible Liver Transplantation Using Antigen-specific Immunoadsorption Columns;Therapeutic Apheresis and Dialysis;2010-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3